Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2 Jillian.Romeo@isoplexis.com Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2 Read More »
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture Jillian.Romeo@isoplexis.com Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture Read More »
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy Jillian.Romeo@isoplexis.com Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy Read More »
Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy Jillian.Romeo@isoplexis.com Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy Read More »
Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform Jillian.Romeo@isoplexis.com Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform Read More »
Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence Jillian.Romeo@isoplexis.com Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence Read More »
Multiparameter Single-Cell Characterization of Ovarian Intratumor Heterogeneity simplomarketing Multiparameter Single-Cell Characterization of Ovarian Intratumor Heterogeneity Read More »
Broadly neutralizing antibodies target the coronavirus fusion peptide simplomarketing Broadly neutralizing antibodies target the coronavirus fusion peptide Read More »
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern simplomarketing Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern Read More »
Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 simplomarketing Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 Read More »
